Breakthrough Treatment Option for COPD / Emphysema
The New Option for Your Patients Who Feel Breathless Despite Medical Therapy
The Zephyr Endobronchial Valve is proven to improve lung function, exercise capacity and quality of life for patients who suffer from severe emphysema.1
Patients treated with Zephyr Valve reported they could breathe easier, be more active and have more confidence being away from home.1
See How Zephyr Valves Work to Reduce Hyperinflation and Improve Lung Function
The Zephyr Valve is the first FDA approved minimally invasive bronchoscopic treatment for severe emphysema patients.
Zephyr Valve treatment is clinically proven safe and effective
Results from multiple randomized clinical trials of the Zephyr Valve have demonstrated clinically meaningful benefits in lung function, exercise capacity and quality of life out to at least one year.1
International Guidance Documents Include Endobronchial Valve Treatment as an Option for Emphysema Patients
Multiple independent networks have concluded that with proper patient selection, the Zephyr Valve procedure should be considered in the treatment of severe emphysema.
GOLD
Global Initiative for Chronic Obstructive Lung Disease
“At 3 months they [patients] get all their improvement in lung function, but their exercise tolerance continues to improve to 6 months and to a year afterward because of the reconditioning effect.”
Zephyr Valve is a Breakthrough Technology7 approved by the FDA for severe emphysema patients.
“This represents a breakthrough technology as the device offers bronchoscopic lung volume reduction without surgery and its associated risks. This device offers significant clinically meaningful advantage over the current standard of care and therefore its availability is also in the best interests of the patients.”7- Food and Drug Administration
